selected scholarly activity
-
academic article
- Comment to the reply letter: Letter to the Editor: Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect (SMMR, Vol. 28, Issue 2, 2019). Statistical Methods in Medical Research. 28:1603-1603. 2019
- Letter to the Editor: Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect (SMMR, Vol. 28, Issue 2, 2019). Statistical Methods in Medical Research. 28:1597-1598. 2019
- Development of a Preliminary Ultrasonographic Enthesitis Score in Psoriatic Arthritis — GRAPPA Ultrasound Working Group. Journal of Rheumatology. 46:384-390. 2019
- The effect of omitted covariates in marginal and partially conditional recurrent event analyses. Lifetime Data Analysis. 25:280-300. 2019
- The association between blood donor sex and age and transfusion recipient mortality: an exploratory analysis. Transfusion. 59:482-491. 2019
- The association between occupational-related mechanical stress and radiographic damage in psoriatic arthritis. Seminars in Arthritis and Rheumatism. 48:638-643. 2019
- Observing Blood Management Programs through the Retrospectroscope. Anesthesiology. 129:1060-1062. 2018
- Tracing studies in cohorts with attrition: Selection models for efficient sampling. Statistics in Medicine. 37:2354-2366. 2018
- Design of cancer trials based on progression-free survival with intermittent assessment. Statistics in Medicine. 37:1947-1959. 2018
- Second-Order Estimating Equations for Clustered Current Status Data from Family Studies Using Response-Dependent Sampling. Statistics in Biosciences. 10:160-183. 2018
- Association of Tumor Necrosis Factor Inhibitor Treatment With Reduced Indices of Subclinical Atherosclerosis in Patients With Psoriatic Disease. Arthritis and Rheumatology. 70:408-416. 2018
- Genome-wide analysis of disease progression in age-related macular degeneration. Human Molecular Genetics. 27:929-940. 2018
- Variable selection and prediction in biased samples with censored outcomes. Lifetime Data Analysis. 24:72-93. 2018
- In-vivo imaging of the microvasculature of the soft tissue margins of osteonecrotic jaw lesions. British Dental Journal. 223:699-705. 2017
- Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trial. The Lancet Haematology. 4:e544-e552. 2017
- Sensitivity and Specificity of Radiographic Scoring Instruments for Detecting Change in Axial Psoriatic Arthritis. Arthritis Care and Research. 69:1700-1705. 2017
- Comparison of Spot Urine Protein to Creatinine Ratio to 24-Hour Proteinuria to Identify Important Change Over Time in Proteinuria in Lupus. Journal of Clinical Rheumatology. 23:301-307. 2017
- Rapid ex vivo examination of Mohs specimens using optical coherence tomography. Photodiagnosis and Photodynamic Therapy. 19:243-248. 2017
- A two-phase model for chronic disease processes under intermittent inspection. Statistics in Medicine. 36:2016-2031. 2017
- Demonstrating therapeutic equivalence of a new and established pharmaceutical or intervention: a guide for the non-statistician. Transfusion. 57:1343-1346. 2017
- Rapid Bacterial Detection during Endodontic Treatment. Critical Reviews in Oral Biology and Medicine Journal of Dental Research. 96:626-632. 2017
- Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores. Genetics. 206:119-133. 2017
- Group O RBCs: where is universal donor blood being used. Vox Sanguinis. 112:336-342. 2017
- Short-Term versus Long-Term Blood Storage. New England Journal of Medicine. 376:1091-1094. 2017
- The Development of Psoriatic Arthritis in Patients With Psoriasis Is Preceded by a Period of Nonspecific Musculoskeletal Symptoms: A Prospective Cohort Study. Arthritis and Rheumatology. 69:622-629. 2017
- The Risk of Developing Diabetes Mellitus in Patients with Psoriatic Arthritis: A Cohort Study. Journal of Rheumatology. 44:286-291. 2017
- Statistical methods for incomplete data: Some results on model misspecification. Statistical Methods in Medical Research. 26:248-267. 2017
- Understanding non-inferiority trials and tests for the non-statistician: when to use them and how to interpret them. Transfusion. 57:240-243. 2017
- Goodness-of-fit test for monotone proportional subdistribution hazards assumptions based on weighted residuals. Statistics in Medicine. 36:362-377. 2017
- Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion. New England Journal of Medicine. 375:1937-1945. 2016
- The Association of HLA-class I Genes and the Extent of Atherosclerotic Plaques in Patients with Psoriatic Disease. Journal of Rheumatology. 43:1844-1851. 2016
- Transfusion-related alloimmunization in children: epidemiology and effects of chemotherapy. Vox Sanguinis. 111:299-307. 2016
- Incidence and predictors for cardiovascular events in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 75:1680-1686. 2016
- Augmented composite likelihood for copula modeling in family studies under biased sampling. Biostatistics. 17:437-452. 2016
- Clinical and Demographic Characteristics of Erosion-free and Erosion-present Status in Psoriatic Arthritis in a Cohort Study. Journal of Rheumatology. 43:1057-1062. 2016
- Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. The Lancet Haematology. 3:e246-e254. 2016
- Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. The Lancet Haematology. 3:E246-E254. 2016
- Sieve estimation in a Markov illness-death process under dual censoring. Biostatistics. 17:kxv042-kxv042. 2016
- The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study. Arthritis and Rheumatology. 68:915-923. 2016
- Gene-Based Association Analysis for Censored Traits Via Fixed Effect Functional Regressions. Genetic Epidemiology. 40:133-143. 2016
- The Incidence and Predictors of Infection in Psoriasis and Psoriatic Arthritis: Results from Longitudinal Observational Cohorts. Journal of Rheumatology. 43:362-366. 2016
- Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized Trial. Transfusion Medicine Reviews. 30:25-29. 2016
- Bias in progression-free survival analysis due to intermittent assessment of progression. Statistics in Medicine. 34:3181-3193. 2015
- Does Cox analysis of a randomized survival study yield a causal treatment effect?. Lifetime Data Analysis. 21:579-593. 2015
- Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 74:1830-1835. 2015
- Adaptive sampling in two-phase designs: a biomarker study for progression in arthritis. Statistics in Medicine. 34:2899-2912. 2015
- Analysis of interval-censored recurrent event processes subject to resolution. Biometrical Journal. 57:725-742. 2015
- Penalized regression for interval-censored times of disease progression: Selection of HLA markers in psoriatic arthritis. Biometrics. 71:782-791. 2015
- Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome. Blood. 126:486-493. 2015
- A Cox-Aalen Model for Interval-censored Data. Scandinavian Journal of Statistics. 42:414-426. 2015
- Multiple imputation for the analysis of incomplete compound variables. Canadian Journal of Statistics. 43:240-264. 2015
- Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab.. Journal of Gastrointestinal Oncology. 6:274-279. 2015
- Minimal Disease Activity and Anti-Tumor Necrosis Factor Therapy in Psoriatic Arthritis. Arthritis Care and Research. 67:842-847. 2015
- Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 74:813-817. 2015
- Sample size and robust marginal methods for cluster-randomized trials with censored event times. Statistics in Medicine. 34:901-923. 2015
- Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses. Transfusion. 55:364-372. 2015
- Factors Explaining the Discrepancy Between Physician and Patient Global Assessment of Joint and Skin Disease Activity in Psoriatic Arthritis Patients. Arthritis Care and Research. 67:264-272. 2015
- Changing Pattern of Sputum Cell Counts During Successive Exacerbations of Chronic Obstructive Pulmonary Disease.. COPD: Journal of Chronic Obstructive Pulmonary Disease. 12:628-635. 2015
- Multimodal optical characterisation of collagen photodegradation by femtosecond infrared laser ablation. The Analyst. 139:6135-6143. 2014
- Composite likelihood for joint analysis of multiple multistate processes via copulas. Biostatistics. 15:690-705. 2014
- Reliability of Radiographic Scoring Methods in Axial Psoriatic Arthritis. Arthritis Care and Research. 66:1417-1422. 2014
- Kidney Function After Off-Pump or On-Pump Coronary Artery Bypass Graft Surgery. JAMA - Journal of the American Medical Association. 311:2191-2191. 2014
- Response-dependent two-phase sampling designs for biomarker studies. Canadian Journal of Statistics. 42:268-284. 2014
- External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR). Thrombosis and Haemostasis. 112:692-699. 2014
- Inverse probability weighted estimating equations for randomized trials in transfusion medicine. Statistics in Medicine. 32:4380-4399. 2013
- A copula model for marked point processes. Lifetime Data Analysis. 19:463-489. 2013
- Authors' redress on ‘Robustness of methods for blinded sample size re-estimation with overdispersed count data’. Statistics in Medicine. 32:3955-3957. 2013
- The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood. 122:1946-1953. 2013
- Clinical trials evaluating pathogen-reduced platelet products: methodologic issues and recommendations. Transfusion. 53:1843-1855. 2013
- Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features—An exploratory analysis of placebo-controlled trials. Journal of Bone Oncology. 2:70-76. 2013
- Rehabilitation in Home Care Is Associated With Functional Improvement and Preferred Discharge. Archives of Physical Medicine and Rehabilitation. 94:1038-1047. 2013
- Soluble Biomarkers Associated with Response to Treatment with Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis. Journal of Rheumatology. 40:866-871. 2013
- Skeletal-related Events and Clinical Outcomes in Patients with Bone Metastases and Normal Levels of Osteolysis: Exploratory Analyses. Clinical Oncology Comparative Haematology International. 25:217-226. 2013
- Regression with incomplete covariates and left-truncated time-to-event data. Statistics in Medicine. 32:1004-1015. 2013
- A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. European Journal of Haematology. 90:121-126. 2013
- Incomplete Data in Randomized Dermatology Trials: Consequences and Statistical Methodology. Dermatology. 226:19-27. 2013
- Misspecification of Cox regression models with composite endpoints. Statistics in Medicine. 31:3545-3562. 2012
- Serum Lactate Dehydrogenase Is Prognostic for Survival in Patients with Bone Metastases from Breast Cancer: A Retrospective Analysis in Bisphosphonate-Treated Patients. Clinical Cancer Research. 18:6348-6355. 2012
- Marginal methods for clustered longitudinal binary data with incomplete covariates. Journal of Statistical Planning and Inference. 142:2819-2831. 2012
- Acute Hepatic Necrosis and Ischemic Limb Necrosis. New England Journal of Medicine. 367:879-881. 2012
- The effect of blood storage duration on in-hospital mortality: a randomized controlled pilot feasibility trial. Transfusion. 52:1203-1212. 2012
- Prognostic Role of Serum Parathyroid Hormone Levels in Advanced Prostate Cancer Patients Undergoing Zoledronic Acid Administration. Oncologist. 17:645-652. 2012
- Testing for Monotone Trend in Recurrent Event Processes. Technometrics. 54:147-158. 2012
-
Measurement of the centrality dependence of the charged particle pseudorapidity distribution in lead–lead collisions at
- A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood. 119:1356-1362. 2012
- The association between smoking and the development of psoriatic arthritis among psoriasis patients. Annals of the Rheumatic Diseases. 71:219-224. 2012
- Coronary Artery Bypass Grafting Surgery Off- or On-pump Revascularisation Study (CORONARY): kidney substudy analytic protocol of an international randomised controlled trial. BMJ Open. 2:e001080-e001080. 2012
- Intraoperative anticoagulation and limb amputations in patients with immune heparin-induced thrombocytopenia who require vascular surgery. Journal of Thrombosis and Haemostasis. 10:148-150. 2012
- Microbiochemical Analysis of Carious Dentine Using Raman and Fluorescence Spectroscopy. Caries Research. 46:432-440. 2012
- Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group. Current Controlled Trials in Cardiovascular Medicine Trials. 12:48. 2011
- Cardiovascular and other comorbidities in patients with psoriatic arthritis: A comparison with patients with psoriasis. Arthritis Care and Research. 63:1729-1735. 2011
- Causal inference in nonrandomized studies via propensity score methods. Transfusion. 51:2536-2539. 2011
- Consensus on the utility of bone markers in the malignant bone disease setting. Critical Reviews in Oncology/Hematology. 80:411-432. 2011
- Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?. Annals of the Rheumatic Diseases. 70:2152-2154. 2011
- Information in the sample covariate distribution in prevalent cohorts: Addendum. Statistics in Medicine. 30:3166-3166. 2011
- Effect of Pregnancy on Ankylosing Spondylitis: A Case-Control Study. Journal of Rheumatology. 38:2442-2444. 2011
- Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes. Arthritis Care and Research. 63:1440-1447. 2011
- A special issue of CJS in honour of Jack Kalbfleisch and Jerry Lawless. Canadian Journal of Statistics. 39:385-386. 2011
- Clinical Correlates of Urolithiasis in Ankylosing Spondylitis. Journal of Rheumatology. 38:1953-1956. 2011
- Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care and Research. 63:1091-1097. 2011
- Iron-containing micronutrient powder provided to children with moderate-to-severe malnutrition increases hemoglobin concentrations but not the risk of infectious morbidity: a randomized, double-blind, placebo-controlled, noninferiority safety trial. American Journal of Clinical Nutrition. 94:585-593. 2011
- The Spondyloarthritis Research Consortium of Canada Registry for Spondyloarthritis. Journal of Rheumatology. 38:1343-1348. 2011
- Whole stimulated salivary flow: Correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjögren's syndrome but not patients with sicca. Arthritis and Rheumatism. 63:2014-2020. 2011
- The Impact of Retardance Pattern Variability on Nerve Fiber Layer Measurements over Time Using GDx with Variable and Enhanced Corneal Compensation. Investigative Ophthalmology and Visual Science. 52:4516-4516. 2011
- Information in the sample covariate distribution in prevalent cohorts. Statistics in Medicine. 30:1397-1409. 2011
- Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancer. Cancer. 117:2077-2085. 2011
- Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care and Research. 63:619-622. 2011
- A robust pairwise likelihood method for incomplete longitudinal binary data arising in clusters. Canadian Journal of Statistics. 39:34-51. 2011
- Magnetically assisted delivery of cells using a magnetic resonance imaging system. Journal Physics D: Applied Physics. 44:055001-055001. 2011
- Composite outcomes in clinical trials: what are they and when should they be used?. Transfusion. 51:11-13. 2011
- Impact of laboratory testing for heparin-induced antibodies: using Bayes' rule to prevent overdiagnosis of heparin-induced thrombocytopenia/Bedeutung von Laboruntersuchungen von Heparin-induzierten Antikörpern: Einsatz des Bayes Wahrscheinlichkeitstheorems zur Prävention der Überdiagnose einer Heparin-induzierten Thrombozytopenie. Laboratoriums Medizin. 35:45-54. 2011
- Progressive multi-state models for informatively incomplete longitudinal data. Journal of Statistical Planning and Inference. 141:80-93. 2011
- The Association Between Diurnal Variation of Optic Nerve Head Topography and Intraocular Pressure and Ocular Perfusion Pressure in Untreated Primary Open-angle Glaucoma. Journal of Glaucoma. 20:44-50. 2011
- Zoledronic acid use in cancer patients. Cancer. 117:11-23. 2011
- Inverse Probability of Censoring Weighted Estimates of Kendall's τ for Gap Time Analyses. Biometrics. 66:1145-1152. 2010
- Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?. Annals of the Rheumatic Diseases. 69:2160-2164. 2010
- Prognostic factors for skeletal complications from metastatic bone disease in breast cancer. Breast Cancer Research and Treatment. 123:767-779. 2010
- Recurrent event analyses. Lifetime Data Analysis. 16:449-450. 2010
- Hypothesis testing in clinical and basic science research. Transfusion. 50:1878-1880. 2010
- CANadian Network and Centre for Trials INternationally (CANNeCTIN): A national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus. Canadian Journal of Cardiology. 26:353-358. 2010
- Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care and Research. 62:970-976. 2010
- Predictors of response to intra-articular steroid injection in psoriatic arthritis. Rheumatology. 49:1367-1373. 2010
- Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology. 49:1399-1405. 2010
- Time and predictors of response to tumour necrosis factor- blockers in psoriatic arthritis: an analysis of a longitudinal observational cohort. Rheumatology. 49:1361-1366. 2010
- An in vitro evaluation of microtensile bond strengths of two adhesive bonding agents to residual dentine after caries removal using three excavation techniques. Journal of Dentistry. 38:480-489. 2010
- Regression Analysis with a Misclassified Covariate from a Current Status Observation Scheme. Biometrics. 66:415-425. 2010
- Analysis of interval-censored disease progression data via multi-state models under a nonignorable inspection process. Statistics in Medicine. 29:1175-1189. 2010
- Duration of red cell storage before transfusion and in-hospital mortality. American Heart Journal. 159:737-743.e1. 2010
- Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease. Leukemia. 24:1043-1049. 2010
- Risk Factors for Axial Inflammatory Arthritis in Patients with Psoriatic Arthritis. Journal of Rheumatology. 37:809-815. 2010
- Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization. Journal of Thrombosis and Haemostasis. 8:504-512. 2010
- Weighted Generalized Estimating Functions for Longitudinal Response and Covariate Data That Are Missing at Random. Journal of the American Statistical Association. 105:336-353. 2010
- A copula-based mixed Poisson model for bivariate recurrent events under event-dependent censoring. Statistics in Medicine. 29:n/a-n/a. 2010
- The analysis of treatment effects for recurring episodic conditions. Statistics in Medicine. 29:n/a-n/a. 2010
- Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity. BMC Cancer. 9:272. 2009
- FALL-RELATED HIP FRACTURES. Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 64A:1199-1199. 2009
- Measuring and reporting the effect of an intervention: absolute measures. Transfusion. 49:2022-2023. 2009
- Measuring and reporting the effect of an intervention: absolute measures. Transfusion. 49:2022-2023. 2009
- Second-order estimating equations for the analysis of clustered current status data. Biostatistics. 10:756-772. 2009
- Two-stage design of clinical trials involving recurrent events. Statistics in Medicine. 28:2617-2638. 2009
- International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis and Rheumatism. 61:1235-1242. 2009
- Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses (vol 46, pg 1286, 2006). Transfusion. 49:2012-2012. 2009
- Likelihood analysis of joint marginal and conditional models for longitudinal categorical data. Canadian Journal of Statistics. 37:182-205. 2009
- Studies of the immune response in heparin-induced thrombocytopenia. Blood. 113:4963-4969. 2009
- Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. Journal of Thrombosis and Haemostasis. 7:676-684. 2009
- Risk Factors for Hip Fracture in Older Home Care Clients. Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 64A:403-410. 2009
- Robust Estimation of Mean Functions and Treatment Effects for Recurrent Events Under Event-Dependent Censoring and Termination: Application to Skeletal Complications in Cancer Metastatic to Bone. Journal of the American Statistical Association. 104:60-75. 2009
- The analysis of multivariate recurrent events with partially missing event types. Lifetime Data Analysis. 15:41-58. 2009
- A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood. 113:1564-1573. 2009
- Measuring and reporting the effect of an intervention: relative measures. Transfusion. 49:9-12. 2009
- Analysis of interval-censored data from clustered multistate processes: application to joint damage in psoriatic arthritis. Journal of the Royal Statistical Society. Series C: Applied Statistics. 57:553-566. 2008
- Bone markers and their prognostic value in metastatic bone disease: Clinical evidence and future directions. Cancer Treatment Reviews. 34:629-639. 2008
- Dissolution characteristics of extrusion freeformed hydroxyapatite–tricalcium phosphate scaffolds. Journal of Materials Science: Materials in Medicine. 19:3345-3353. 2008
- Meningioma as a cause of chronic orofacial pain: case reports. British Journal of Oral and Maxillofacial Surgery British Journal of Oral Surgery. 46:487-489. 2008
- Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid. Cancer. 113:193-201. 2008
- Analysis of a nonsusceptible fraction with current status data. Statistics in Medicine. 27:2715-2730. 2008
- The role of noninferiority designs in clinical research. Transfusion. 48:1050-1052. 2008
- Single wavelength micro-endoscopy in non-surgical vascular lesion diagnosis & characterization. Journal of Microscopy. 230:203-211. 2008
- Regression analysis of multivariate panel count data. Biostatistics. 9:234-248. 2008
- Operative Dentistry and the Abuse of Dental Hard Tissues: Confocal Microscopical Imaging of Cutting. Operative Dentistry. 33:215-224. 2008
- Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity. Journal of Thoracic Oncology. 3:228-236. 2008
- A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion. 0:071003012013009-???. 2008
- An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts. Thrombosis and Haemostasis. 100:01-12. 2008
- Sintering behaviour of calcium phosphate filaments for use as hard tissue scaffolds. Journal of the European Ceramic Society. 28:159-167. 2008
- Designing laboratory-based research studies: is it time for a change?. Transfusion. 47:2336-2337. 2007
- Non-inferiority trial design for recurrent events. Statistics in Medicine. 26:4563-4577. 2007
- Achieving transparency in implementing abortion laws. International Journal of Gynecology and Obstetrics Journal of the International Federation of Gynaecology and Obstetrics. 99:157-161. 2007
- Erratum for “A new preference-based analysis for randomized trials can estimate treatment acceptability and effect in complaint patients” [J Clin Epidemiol 59 (2006) 685–696]. Journal of Clinical Epidemiology. 60:1203-1203. 2007
- Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer. 110:1860-1867. 2007
- Changing pattern of sputum cell counts during successive exacerbations of airway disease. Respiratory Medicine. 101:2217-2220. 2007
- Reproductive health and public health ethics. International Journal of Gynecology and Obstetrics Journal of the International Federation of Gynaecology and Obstetrics. 99:75-79. 2007
- Zoledronic Acid and Survival in Breast Cancer Patients with Bone Metastases and Elevated Markers of Osteoclast Activity. Oncologist. 12:1035-1043. 2007
- Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity.. Oncologist. 12:1035-1043. 2007
- International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures.. Journal of Rheumatology. 34:1733-1739. 2007
- International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis.. Journal of Rheumatology. 34:1740-1745. 2007
- Predictors of Skeletal Complications in Men with Hormone-Refractory Metastatic Prostate Cancer. Urology. 70:315-319. 2007
- Clinical Utility of Biochemical Markers of Bone Metabolism for Improving the Management of Patients with Advanced Multiple Myeloma. Clinical Lymphoma Clinical Lymphoma and Myeloma. 7:346-353. 2007
- Transition Models for Multivariate Longitudinal Binary Data. Journal of the American Statistical Association. 102:211-223. 2007
- Time-correlated single-photon counting fluorescence lifetime confocal imaging of decayed and sound dental structures with a white-light supercontinuum source. Journal of Microscopy. 225:126-136. 2007
- Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura. Annals of Internal Medicine. 146:25-25. 2007
- Acquiring human embryos for stem-cell research. International Journal of Gynecology and Obstetrics Journal of the International Federation of Gynaecology and Obstetrics. 96:67-71. 2007
- Bleeding during critical illness: a prospective cohort study using a new measurement tool.. Clinical and Investigative Medicine. 30:E93-102. 2007
- A study of the agreement between patient self-assessment and study personnel assessment of bleeding symptoms. Transfusion. 46:1926-1933. 2006
- Legal abortion for mental health indications. International Journal of Gynecology and Obstetrics Journal of the International Federation of Gynaecology and Obstetrics. 95:185-190. 2006
- The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia.. Haematologica. 91:1530-1537. 2006
- Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference. Clinical Cancer Research. 12:6209s-6212s. 2006
- Women's access to health care: The legal framework. International Journal of Gynecology and Obstetrics Journal of the International Federation of Gynaecology and Obstetrics. 94:216-225. 2006
- A novel real-time confocal imaging technique for examining host–implant interfacial shear failure patterns. Journal of Microscopy. 223:96-106. 2006
- The Values of Additive Forms at Prime Arguments. Rocky Mountain Journal of Mathematics. 36:1153-1164. 2006
- Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses. Transfusion. 46:1286-1291. 2006
- A new preference-based analysis for randomized trials can estimate treatment acceptability and effect in compliant patients. Journal of Clinical Epidemiology. 59:685-696. 2006
- Legal and ethical issues in telemedicine and robotics. International Journal of Gynecology and Obstetrics Journal of the International Federation of Gynaecology and Obstetrics. 94:73-78. 2006
- A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion. 46:903-911. 2006
- Markers of Bone Metabolism and Survival in Men with Hormone-Refractory Metastatic Prostate Cancer. Clinical Cancer Research. 12:3361-3367. 2006
- Reliability of electrocardiogram interpretation in critically ill patients*. Critical Care Medicine. 34:1338-1343. 2006
- Clinical and radiological damage in psoriatic arthritis. Annals of the Rheumatic Diseases. 65:478-481. 2006
- Avoiding Transfusions in Children Undergoing Cardiac Surgery: A Meta-Analysis of Randomized Trials of Aprotinin. Anesthesia and Analgesia. 102:731-737. 2006
- Implications of Model Misspecification in Robust Tests for Recurrent Events. Lifetime Data Analysis. 12:69-95. 2006
- Anterior Optic Nerve Capillary Blood Flow Response to Diurnal Variation of Mean Ocular Perfusion Pressure in Early Untreated Primary Open-Angle Glaucoma. Investigative Ophthalmology and Visual Science. 46:4581-4581. 2005
- Anterior optic nerve capillary blood flow response to diurnal variation of mean ocular perfusion pressure in early untreated primary open-angle glaucoma. Investigative Ophthalmology and Visual Science. 46:4581-4587. 2005
- Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood. 106:3791-3796. 2005
- Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency. Journal of Critical Care. 20:357-363. 2005
- Robust Tests for Treatment Effects Based on Censored Recurrent Event Data Observed over Multiple Periods. Biometrics. 61:692-701. 2005
- Survival-Adjusted Multiple-Event Analysis for the Evaluation of Treatment Effects of Zoledronic Acid in Patients with Bone Metastases from Solid Tumors. Supportive Cancer Therapy. 2:234-240. 2005
- Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial. Transfusion. 45:896-903. 2005
- Natural History of Rising Serum Prostate-Specific Antigen in Men With Castrate Nonmetastatic Prostate Cancer. Journal of Clinical Oncology. 23:2918-2925. 2005
- Statistical methods for multivariate interval-censored recurrent events. Statistics in Medicine. 24:671-691. 2005
- Relative Change in Diurnal Mean Ocular Perfusion Pressure: A Risk Factor for the Diagnosis of Primary Open-Angle Glaucoma. Investigative Ophthalmology and Visual Science. 46:561-561. 2005
- Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors. Journal of the National Cancer Institute. 97:59-69. 2005
- Prediction of falls using a risk assessment tool in the acute care setting. BMC Medicine. 2:1. 2004
- Marginal Analysis of Incomplete Longitudinal Binary Data: A Cautionary Note on LOCF Imputation. Biometrics. 60:820-828. 2004
- Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers. Transfusion. 44:1135-1142. 2004
- A Conditional Markov Model for Clustered Progressive Multistate Processes under Incomplete Observation. Biometrics. 60:436-443. 2004
- The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada.. Journal of Rheumatology. 31:1126-1131. 2004
- Tests for multivariate recurrent events in the presence of a terminal event. Biostatistics. 5:129-143. 2004
- A 6-Mo Home-Based Exercise Program May Slow Vertebral Height Loss. Journal of Clinical Densitometry. 6:391-400. 2003
- LETTERS TO THE EDITOR. Transfusion. 43:1763-1763. 2003
- Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporosis International. 14:913-917. 2003
- Efficacy of home-based exercise for improving quality of life among elderly women with symptomatic osteoporosis-related vertebral fractures. Osteoporosis International. 14:677-682. 2003
- Conditional analysis of mixed Poisson processes with baseline counts: implications for trial design and analysis. Biostatistics. 4:479-494. 2003
- Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion. 43:742-752. 2003
- Monitoring the evolutionary process of quality: Risk-adjusted charting to track outcomes in intensive care. Critical Care Medicine. 31:1676-1682. 2003
- Incremental net benefit in randomized clinical trials with quality-adjusted survival. Statistics in Medicine. 22:353-362. 2003
- Regression modeling with recurrent events and time-dependent interval-censored marker data.. Lifetime Data Analysis. 9:275-291. 2003
- Efficacy of Bisphosphonates in the Management of Skeletal Complications of Bone Metastases and Selection of Clinical Endpoints. American Journal of Clinical Oncology. 25:S10-S18. 2002
- Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints.. American Journal of Clinical Oncology. 25:S10-S18. 2002
- Marginal Methods for Incomplete Longitudinal Data Arising in Clusters. Journal of the American Statistical Association. 97:1071-1080. 2002
- Using inverse-weighting in cost-effectiveness analysis with censored data. Statistical Methods in Medical Research. 11:539-551. 2002
- Video-rate confocal endoscopy. Journal of Microscopy. 207:37-42. 2002
- Response. Journal of Clinical Epidemiology. 55:532-532. 2002
- Analysis of repeated events. Statistical Methods in Medical Research. 11:141-166. 2002
- Selection effects in randomized trials with count data. Statistics in Medicine. 21:515-531. 2002
- SEMIPARAMETRIC CONFIDENCE INTERVALS BASED ON ESTIMATING FUNCTIONS. Communications in Statistics - Theory and Methods. 31:1701-1708. 2002
- Response. Journal of Clinical Epidemiology. 55:103-103. 2002
- Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study. The Lancet. 358:1941-1945. 2001
- Multiple organ dysfunction: Baseline and serial component scores. Critical Care Medicine. 29:2046-2050. 2001
- Synthesis of Evidence from Epidemiological Studies with Interval-Censored Exposure Due to Grouping. Biometrics. 57:671-680. 2001
- Some comments on efficiency gains from auxiliary information for right-censored data. Journal of Statistical Planning and Inference. 96:191-202. 2001
- The Long-Term Use of Azathioprine in Patients with Psoriatic Arthritis. Journal of Clinical Rheumatology. 7:160-165. 2001
- Remission in psoriatic arthritis.. Journal of Rheumatology. 28:1045-1048. 2001
- Risk-Adjusted Monitoring of Binary Surgical Outcomes. Medical Decision Making. 21:163-169. 2001
- Risk-Adjusted Monitoring of Binary Surgical Outcomes. Medical Decision Making. 21:163-169. 2001
- Methodology for Treatment Evaluation in Patients With Cancer Metastatic to Bone. Journal of the National Cancer Institute. 93:534-538. 2001
- Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis.. Arthritis and Rheumatism. 45:151-158. 2001
- Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.. Journal of Rheumatology. 28:761-765. 2001
- Chromosome number determinations in fam. Compositae, tribe Astereae. VI. Western North American taxa and comments on generic treatments of North American asters.. Rhodora. 103:202-218. 2001
- When should an effective treatment be used?. Journal of Clinical Epidemiology. 54:253-262. 2001
- Agreement between Alternative Classifications of Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 163:490-493. 2001
- A meta-analysis of mammography screening promotion.. Cancer Detection and Prevention Cancer Epidemiology. 25:147-160. 2001
- Estimation of Operating Characteristics for Dependent Diagnostic Tests Based on Latent Markov Models. Biometrics. 56:1109-1117. 2000
- Monitoring surgical performance using risk-adjusted cumulative sum charts. Biostatistics. 1:441-452. 2000
- Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.. Journal of Rheumatology. 27:1892-1895. 2000
- A comparison of some random effect models for parameter estimation in recurrent events. Mathematical and Computer Modelling. 32:11-26. 2000
- A meta-analysis of case-control and cohort studies with interval-censored exposure data: application to chorionic villus sampling. Biostatistics. 1:203-217. 2000
- Methods for assessing responsiveness. Journal of Clinical Epidemiology. 53:459-468. 2000
- Interobserver Variation in Interpreting Chest Radiographs for the Diagnosis of Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 161:85-90. 2000
- Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Critical Care Medicine. 27:2812-2817. 1999
- Validity assessment of the disabilities of arm, shoulder, and hand questionnaire (DASH) for patients with psoriatic arthritis.. Journal of Rheumatology. 26:2191-2194. 1999
- A Mixed Model for Two-State Markov Processes Under Panel Observation. Biometrics. 55:915-920. 1999
- Adjusted Score Tests of Homogeneity for Poisson Processes. Journal of the American Statistical Association. 94:308-319. 1999
- The Utility of Mixed-Form Likelihoods. Biometrics. 55:284-288. 1999
- Two-state mixed renewal processes for chronic disease. Statistics in Medicine. 18:175-188. 1999
- Monitoring paired binary surgical outcomes using cumulative sum charts. Statistics in Medicine. 18:69-86. 1999
- Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis.. Journal of Rheumatology. 25:2146-2155. 1998
- The use of sulfasalazine in psoriatic arthritis: a clinic experience.. Journal of Rheumatology. 25:1957-1961. 1998
- Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients. Annals of Internal Medicine. 129:433-433. 1998
- Radiological assessment in psoriatic arthritis. Rheumatology. 37:760-765. 1998
- HLA markers and progression in psoriatic arthritis.. Journal of Rheumatology. 25:730-733. 1998
- A 1-Year Community-Based Health Economic Study of Ciprofloxacin vs Usual Antibiotic Treatment in Acute Exacerbations of Chronic Bronchitis. Chest. 113:131-141. 1998
- Methodology for clinical trials in rheumatology: logical foundations.. Journal of Rheumatology. 24:1861-1865. 1997
- Comparison of the Effects of Two Doses of Recombinant Hirudin Compared With Heparin in Patients With Acute Myocardial Ischemia Without ST Elevation. Circulation. 96:769-777. 1997
- MARGINAL ANALYSIS OF RECURRENT EVENTS AND A TERMINATING EVENT. Statistics in Medicine. 16:911-924. 1997
- Dietary Calcium and Blood Pressure. Annals of Internal Medicine. 126:492-492. 1997
- A Logistic Model for Trend in 2 x 2 x K Tables with Applications to Meta- Analyses. Biometrics. 53:352-352. 1997
- A Logistic-Bivariate Normal Model for Overdispersed Two-State Markov Processes. Biometrics. 53:358-358. 1997
- Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis.. Journal of Rheumatology. 24:511-517. 1997
- Modeling two-state disease processes with random effects.. Lifetime Data Analysis. 3:315-335. 1997
- Interim Monitoring of Longitudinal Comparative Studies with Recurrent Event Responses. Biometrics. 52:1311-1311. 1996
- Dietary Calcium Supplementation and Blood Pressure-Reply. JAMA - Journal of the American Medical Association. 276:1386-1386. 1996
- Effects of calcium supplementation on pregnancy-induced hypertension - Reply. JAMA - Journal of the American Medical Association. 276:1388-1388. 1996
- Coupled Error Spending Functions for Parallel Bivariate Sequential Tests. Biometrics. 52:442-442. 1996
- Design Considerations in Crossover Trials with a Single Interim Analysis and Serial Patient Entry. Biometrics. 52:732-732. 1996
- Robust Tests for Treatment Comparisons Based on Recurrent Event Responses. Biometrics. 52:557-557. 1996
- Incorporating Surrogate Endpoints into Group Sequential Trials. Biometrical Journal. 38:119-130. 1996
- Multiplicity Considerations in the Design and Analysis of Clinical Trials. Journal of the Royal Statistical Society. Series A: Statistics in Society. 159:93-93. 1996
- Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA - Journal of the American Medical Association. 274:1800-1804. 1995
- Conditional inference for subject-specific and marginal agreement: Two families of agreement measures. Canadian Journal of Statistics. 23:333-344. 1995
- The design and analysis of randomized trials with recurrent events. Statistics in Medicine. 14:2081-2098. 1995
- Interim Analyses in 2 x 2 Crossover Trials. Biometrics. 51:932-932. 1995
- The number needed to treat: a clinically useful measure of treatment effect. British Medical Journal BMJ (Clinical research ed.). 310:452-454. 1995
- Guidelines for Monitoring Efficacy and Toxicity Responses in Clinical Trials. Biometrics. 50:1146-1146. 1994
- Understanding clinical trials. British Medical Journal BMJ (Clinical research ed.). 309:755-756. 1994
- Interim monitoring of bivariate responses using repeated confidence intervals. Controlled Clinical Trials Contemporary Clinical Trials. 15:187-200. 1994
- AN INVALID COMPARISON OF SEVERAL POINT ESTIMATORS OF THE ODDS RATIO IN A SINGLE 2X2 CONTINGENCY TABLE - RESPONSE. Biometrics. 48:1292-1295. 1992
- Canadian Hemodialysis Morbidity Study. American Journal of Kidney Diseases. 19:214-234. 1992
- The Natural History of Asymptomatic Urolithiasis. JOURNAL OF UROLOGY. 147:319-321. 1992
- Stress ulcer prophylaxis in the critically III: A meta-analysis. American Journal of Medicine. 91:519-527. 1991
- Economic significance of take-all on winter wheat in the pacific northwest USA. Crop Protection. 10:391-395. 1991
- A Comparison of Several Point Estimators of the Odds Ratio in a Single 2 X 2 Contingency Table. Biometrics. 47:795-795. 1991
-
conference paper
- The value of carotid ultrasound in cardiovascular risk stratification in patients with psoriatic disease. Arthritis and Rheumatology. 2019
- Exploring the Potential Harm of Short-Term Blood Storage on Patients Undergoing Cardiovascular Surgery. Transfusion. 209A-209A. 2018
- Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies. Transfusion. 2841-2860. 2018
- The American Phytopathological Society: A century plus ten years young. Phytopathology. 2018
- Cardiac Biomarkers and Carotid Atherosclerosis and Its Progression in Psoriatic Disease. Arthritis and Rheumatology. 2018
- Health Care Utilization for Musculoskeletal Issues during the Pre-Diagnosis Period in Psoriatic Arthritis - a Population-Based Study. Arthritis and Rheumatology. 2018
- Is Axial Psoriatic Arthritis Distinct from Ankylosing Spondylitis with and without Concomitant Psoriasis?. Arthritis and Rheumatology. 2018
- Malignancy in Psoriatic Disease. Arthritis and Rheumatology. 2018
- Metabolomics Profile Predicts Carotid Atherosclerosis Progression in Psoriatic Disease. Arthritis and Rheumatology. 2018
- Mortality Rates and Causes in Psoriatic Arthritis Patients. Arthritis and Rheumatology. 2018
- Progression of Unilateral Grade 2 Sacroiliitis in a Psoriatic Arthritis Cohort. Arthritis and Rheumatology. 2018
- Remission in Psoriatic Arthritis: Definition and Predictors. Arthritis and Rheumatology. 2018
- The Value of Carotid Ultrasound in Cardiovascular Risk Stratification in Patients with Psoriatic Disease. Journal of Rheumatology. 997-997. 2018
- The Association Between HLA Genetic Susceptibility Markers and Sonographic Enthesitis in Psoriatic Arthritis. Arthritis and Rheumatology. 756-762. 2018
- The association between sonographic enthesitis and radiographic damage in psoriatic arthritis. Arthritis Research and Therapy Arthritis Research. 189. 2017
- Development of an Ultrasonographic Enthesitis Score for Psoriatic Arthritis Patients. Arthritis and Rheumatology. 2017
- Patterns and Predictors of Progression of Sacroiliitis in Psoriatic Arthritis and Its Relationship with Human Leukocyte Antigen (HLA) Alleles. Results from the Toronto Cohort. Arthritis and Rheumatology. 2017
- The Prevalence, Incidence and Associated Factors for Liver Abnormalities in Psoriatic Arthritis: Resutls from a Longitudinal Observational Cohort. Arthritis and Rheumatology. 2017
- Analysis of Red Blood Cell Storage Duration and in-Hospital Mortality Using Time Dependent Exposure: Is the Oldest Blood Bad?. Transfusion. 33A-33A. 2017
- FRI0522 The association between occupational-related mechanical stress and radiographic damage in psoriatic arthritis. Annals of the Rheumatic Diseases. 688-689. 2017
- OP0111 The association between sonographic enthesitis and radiographic joint damage in psoriatic arthritis. Annals of the Rheumatic Diseases. 98-98. 2017
- TNF alpha Inhibitors are Associated with Reduced Progression of Carotid Atherosclerotic Plaques by Ultrasound and an Improvement in Aortic Arch Vascular Inflammation by 18-FDG PET/CT in Psoriasis and Psoriatic Arthritis Patients - A Prospective Study. Journal of Rheumatology. 859-860. 2017
- The Association Between Sonographic Enthesitis and Radiographic Joint Damage in Psoriatic Arthritis. Journal of Rheumatology. 916-917. 2017
- The Effect of Platelet Transfusion on Death in the Intensive Care Unit. Blood. 2016
- Tnf alpha Inhibitors Are Associated with Reduced Progression of Carotid Atherosclerotic Plaques By Ultrasound and an Improvement in Aortic Arch Vascular Inflammation By 18-FDG PET/CT in Psoriasis and Psoriatic Arthritis Patients - a Prospective Study from Two Cohorts. Arthritis and Rheumatology. 2016
- Informing Fresh Versus Old Red Cell Management (INFORM) Trial: A Large International Pragmatic Randomized Trial. Transfusion. 5A-5A. 2016
- High Level of Inflammation Predicts the Development of Diabetes Mellitus in Patients with Psoriatic Arthritis. Journal of Rheumatology. 1215-1215. 2016
- THU0424 Treatment with Tnf Alpha Blockers Is Associated with Reduced Progression of Atherosclerotic Plaques in Patients with Psoriatic Disease – A Prospective Study. Annals of the Rheumatic Diseases. 343.1-343. 2016
- A Qualitative Research Study to Understand Post-Transfusion Well-Being in Patients with Myelodysplastic Syndromes. Blood. 2015
- Assessing Disease Stability of Patients with Myelodysplastic Syndrome for an Age of Blood Randomized Controlled Trial: A Chart Review. Blood. 2015
- Evaluation of the Predictive Value of Non-Specific Musculoskeletal Symptoms in Preclinical Phases of Psoriatic Arthritis. Arthritis and Rheumatology. 2015
- HLA Class I Genes As Susceptibility Markers of Psoriatic Arthritis in Patients with Psoriasis - a Meta-Analysis. Arthritis and Rheumatology. 2015
- High Level of Inflammation Predicts the Development of Diabetes Mellitus in Patients with Psoriatic Arthritis. Arthritis and Rheumatology. 2015
- Reliability of Radiographic Assessment of Psoriatic Arthritis Mutilans. Arthritis and Rheumatology. 2015
- Exploratory Analysis of a Blood Processing Method and In-hospital Mortality. Transfusion. 23A-23A. 2015
- Exploratory Analysis of the Association Between Donor Sex and Inhospital Mortality in Transfusion Recipients. Transfusion. 23A-24A. 2015
- Group O Red Blood Cells: Where is Universal donor blood Being Used?. Transfusion. 153A-154A. 2015
- Reliability of Radiographic Assessment of Psoriatic Arthritis Mutilans. Journal of Rheumatology. 1287-1287. 2015
- The Incidence and Risk Factors for PsA in Patients with Psoriasis - A Prospective Cohort Study. Journal of Rheumatology. 1307-1308. 2015
- Utilization of Universal Group O Blood By Non Group O Recipients. Blood. 2014
- Ability of Clinical Variables to Predict Radiographic Damage in Psoriatic Arthritis.. Arthritis and Rheumatology. S703-S704. 2014
- Predictors for Cardiovascular Events in Patients with Psoriatic Arthritis - a Cohort Study.. Arthritis and Rheumatology. S236-S236. 2014
- Reversal of Damage in Psoriatic Arthritis. Arthritis and Rheumatology. S696-S697. 2014
- The Incidence and Risk Factors for Psa in Patients with Psoriasis - a Prospective Cohort Study.. Arthritis and Rheumatology. S814-S814. 2014
- A rare cause of combined fifth and seventh nerve symptomatology. Oral Diseases. 28-28. 2014
- Cumulative Exposure to Elevated Inflammatory Markers is Associated with Increased Burden of Atherosclerosis in Psoriatic Arthritis Patients: A Cohort Study. Journal of Rheumatology. 1537-1537. 2014
- Cumulative Exposure To Elevated Inflammatory Markers Is Associated With Increased Burden Of Atherosclerosis In Psoriatic Arthritis Patients: A Cohort Study. Arthritis and Rheumatism. S1189-S1189. 2013
- Factors Explaining The Discrepancy Between Patient and Physician Global Assessment Of Disease Activity In Psoriatic Arthritis. Arthritis and Rheumatism. S150-S150. 2013
- The Association Between Obesity and Radiographic Progression Of Joint Damage Among Patients With Psoriatic Arthritis. Arthritis and Rheumatism. S146-S147. 2013
- The Disease Characteristics and Predictors Of Minimal Disease Activity On TNF Blockers-Results From A Longitudainal Observational Cohort. Arthritis and Rheumatism. S1189-S1190. 2013
- MALE GENDER IS ASSOCIATED WITH ACCELERATED RADIOGRAPHIC PROGRESSION IN AXIAL DAMAGE BUT NOT WITH PROGRESSION OF PERIPHERAL DAMAGE. Annals of the Rheumatic Diseases. 681-681. 2013
- OBESITY IS ASSOCIATED WITH LOWER PROBABILITY OF ACHIEVING SUSTAINED MINIMAL DISEASE ACTIVITY STATE AMONG PATIENTS WITH PSORIATIC ARTHRITIS. Annals of the Rheumatic Diseases. 672-672. 2013
- THE CHARACTERISTICS AND PREDICTORS OF MINIMAL DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS ON TNF BLOCKERS. Annals of the Rheumatic Diseases. 675-675. 2013
- Thrombotic events in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab.. Journal of Clinical Oncology. 2013
- Thrombotic events in patients with metastatic colorectal cancer treated with FOLFIRI plus bevacizumab.. Journal of Clinical Oncology. 540-540. 2013
- Longitudinal co-localised optical coherence tomography and microvascular oral imaging. Oral Diseases. 34-34. 2012
- Mortality, Blood Storage Duration, and Method of Red Cell Production: An Exploratory Analysis. Transfusion. 51A-52A. 2012
- Thalidomide for recalcitrant recurrent oral ulceration: 20 years experience. Oral Diseases. 27-28. 2012
- Parametric Survival Analysis as Well as Multi-State Analysis Confirms the Association between Human Leukocyte Antigen Alleles and the Development of Arthritis Mutilans in Patients with Psoriatic Arthritis. Journal of Rheumatology. 1723-1723. 2012
- Gene environment interaction in psoriasis and psoriatic arthritis: smoking and HLA-C*0602. British Journal of Dermatology. E29-E30. 2011
- Continuance of Non-Steroidal Anti-Inflammatory Drugs May Reduce Radiographic Progression in Ankylosing Spondylitis Patients on Biological Therapy. Arthritis and Rheumatism. S510-S510. 2011
- Does Clinical Examination Underestimate Joint Inflammation In Patients with Psoriatic Arthritis?. Arthritis and Rheumatism. S522-S522. 2011
- Eotaxin: A Novel Biomarker in Ankylosing Spondylitis That Predicts Less Structural Damage. Arthritis and Rheumatism. S644-S645. 2011
- Evidence for a Link Between Inflammation and Radiographic Progression in Ankylosing Spondylitis. Arthritis and Rheumatism. S201-S201. 2011
- Profiling NSAID Responders in Ankylosing Spondylitis. Arthritis and Rheumatism. S520-S521. 2011
- Radiographic Scoring Instruments Have High Specificity for Detecting Change in Axial Psoriatic Arthritis. Arthritis and Rheumatism. S972-S973. 2011
- Can We Do a 25,000 Patient Pragmatic Study to Address the Age of Blood and Mortality Controversy? A Pilot to Determine Feasibility. Transfusion. 193A-193A. 2011
- A prospective cohort study of bleeding symptoms among persons referred to hematologists who are diagnosed with or excluded of having bleeding disorders. Journal of Thrombosis and Haemostasis. 687-688. 2011
- Bleeding risks associated with inherited platelet disorders: results from a prospective cohort study. Journal of Thrombosis and Haemostasis. 687-687. 2011
- Response to the First Biologic in Patients with Ankylosing Spondylitis: a Real World Experience. Journal of Rheumatology. 1144-1145. 2011
- Seasonal Variation in Vitamin D Levels in Patients with Psoriatic Arthritis from Northern and Southern Latitudes and its Association with Clinical Outcomes. Journal of Rheumatology. 1149-1150. 2011
- TWO-PHASE SAMPLING FOR CORRELATED RESPONSES. American Journal of Epidemiology. S70-S70. 2011
- Patients with bone metastases from solid tumours and poor prognostic features may gain survival benefits from zoledronic acid. Bone. S20-S21. 2011
- Assessment of disease severity and treatment responses in oral mucosal diseases. Oral Diseases. 539-540. 2010
- Disease severity scoring and efficacy of treatment of oral lichen planus. Oral Diseases. 542-542. 2010
- Evaluation of the efficacy of Colchicine with and without Betnesol mouthwash in management of RAS. Oral Diseases. 546-546. 2010
- Graft vs. Host Disease or Acute Relapse? Cutaneous and Gingival Extramedullary Manifestations of Acute Myeloid Leukaemia following Haemopoietic Stem Cell Transplantation. Oral Diseases. 562-562. 2010
- In vivo micro-vascularoscopy - A longitudinal study on gingival tissue. Oral Diseases. 530-530. 2010
- Oral Disease Severity Scores (ODSS) and Treatment in patients with Recurrent Ulcers. Oral Diseases. 546-546. 2010
- Unexplained thrombocytopenia as a cause for spontaneous gingival bleeding. Oral Diseases. 571-572. 2010
- Correlations between N-telopeptide of type I collagen with survival and fractures in patients with metastatic bone disease from renal cell carcinoma. Bone. S312-S312. 2010
- Natural History of Metastatic Bone Disease in Breast Cancer Based on Site of Bone Lesions. Bone. S329-S329. 2010
- Possible Survival Benefits From Zoledronic Acid Treatment in Patients With Bone Metastases From Solid Tumors and Poor Prognostic Features. Bone. S311-S312. 2010
- Zoledronic Acid Treatment Delays Disease Progression and Improves Survival in Patients With Bone Metastases From Solid Tumors and Elevated Levels of Bone Resorption. Bone. S302-S303. 2010
- Documentation of Significant Non-Serological Differences between Primary Sjogren's Syndrome (PSS) and SICCA. Journal of Rheumatology. 1281-1282. 2010
- Environmental Risk Factors for Psoriatic Arthritis Among Patients with Psoriasis - A Case Control Study. Journal of Rheumatology. 1285-1285. 2010
- Estimating functions for evaluating treatment effects in cluster-randomized longitudinal studies in the presence of drop-out and non-compliance. Canadian Journal of Statistics. 232-255. 2010
- Macrophage Migration Inhibition Factor gene polymorphism is associated with relapse in joints that achieved remission after intra-articular steroid injection in psoriatic arthritis. Journal of Rheumatology. 1327-1327. 2010
- Pathological Correlations of Minor Salivary gland Biopsies in Sjogren's Syndrome, and the Importance of stimulated Salivary Flow. Journal of Rheumatology. 1322-1322. 2010
- Prevalence of Vitamin D Insufficiency and Clinical Outcomes in Psoriatic Arthritis Pa tients. Journal of Rheumatology. 1347-1347. 2010
- Reliability of Radiographic Scoring Methods in Axial Psoriatic Arthritis (AxPsA). Journal of Rheumatology. 1320-1320. 2010
- Response to TNF-alpha Blockers in Psoriatic Arthritis - An Observational Cohort Study. Journal of Rheumatology. 1285-1285. 2010
- Soluble Biomarkers Predict Response to Anti-Tumour Necrosis Factor (TNF) Therapy in Psoriatic Arthritis (PsA). Journal of Rheumatology. 1282-1283. 2010
- Natural history of castration-resistant nonmetastatic prostate cancer: Secondary analyses of a multicenter randomized controlled trial.. Journal of Clinical Oncology. 4653-4653. 2010
- OC-095 A clinical overview of the presentation and management of orofacial granulomatosis in a combined oral medicine and gastroenterology clinic. Gut. A39.2-A40. 2010
- Oral iron supplementation with a micronutrient powder (Sprinkles (R)) provided to children with moderate-to-severe malnutrition does not increase infectious morbidity risk: a randomized, double-blind, placebo-controlled, non-inferiority safety trial. FASEB Journal. 2010
- Predictors of Response to Intra-Articular Steroid Injection In Psoriatic Arthritis. Journal of Rheumatology. 2569-2570. 2009
- A Bivariate Mover–Stayer Model for Interval-Censored Recurrent Event Data: Application to Joint Damage in Rheumatology. Communications in Statistics - Theory and Methods. 3389-3405. 2009
- Robust Estimation of State Occupancy Probabilities for Interval-Censored Multistate Data: An Application Involving Spondylitis in Psoriatic Arthritis. Communications in Statistics - Theory and Methods. 3307-3325. 2009
- Duration of Red Cell Storage and In-hospital Mortality in Patients with Cardiovascular Disease. Transfusion. 24A-25A. 2009
- International multi-centre Psoriasis and Psoriatic Arthritis reliability trial (GRAPPA-IMPART): Assessment of skin, joints, nails and Dactylitis. Journal of Investigative Dermatology. 1841-1841. 2009
- Correlation of N-telopeptide of type I collagen (NTX) with survival and fractures in patients (pts) with bone metastases from renal cell carcinoma (RCC). Journal of Clinical Oncology. 2009
- ACHIEVING MINIMAL DISEASE ACTIVITY (MDA) CRITERIA DECREASES PROGRESSION OF JOINT DAMAGE IN PSORIATIC ARTHRITIS. Rheumatology. I51-I52. 2009
- FREQUENCY AND PREDICTORS OF MINIMAL DISEASE ACTIVITY IN AN OBSERVATIONAL PSA COHORT. Rheumatology. I50-I50. 2009
- Evaluation of a method to assess platelet function in individuals with thrombocytopenia. Haemophilia. 626-626. 2009
- A345 High Baseline NTX Predicts for Inferior Survival and Shorter Time to First SRE in Multiple Myeloma. Clinical Lymphoma Clinical Lymphoma and Myeloma. S55-S56. 2009
- AN APPROACH FOR THE DEVELOPMENT OF REFERENCE INTERVALS FOR PLATELET AGGREGATION TESTING. American Journal of Hematology. 942-942. 2008
- Frequency and Predictors of Minimal Disease Activity in an Observational PsA Cohort.. Arthritis and Rheumatism. 3997-3997. 2008
- Predictors of Response to Intra-articular Steroid Injection in Psoriatic Arthritis. Arthritis and Rheumatism. 3991-3991. 2008
- Defining psoriatic spondylitis (PsSp). Arthritis and Rheumatism. S365-S365. 2008
- EFFECTS OF ZOLEDRONIC ACID (ZOL) ON SURVIVAL IN PATIENTS WITH METASTATIC BONE DISEASE AND HIGH BONE TURNOVER: RESULTS FROM A META-ANALYSIS. Annals of Oncology. 276-276. 2008
- RISK FACTORS FOR SKELETAL-RELATED EVENT (SRES) IN ZOLEDRONIC ACID-TREATED PATIENTS WITH BONE METASTASES (METS) FROM NON-SMALL CELL LUNG CANCER (NSCLC). Annals of Oncology. 275-275. 2008
- Risk factors for the development of spondylitis in patients with psoriatic arthritis (PsA). Arthritis and Rheumatism. S364-S365. 2008
- THE PROGNOSTIC VALUE OF PAIN SCORES FOR CLINICAL OUTCOMES IN ADVANCED BREAST CANCER (BC), PROSTATE CANCER (PC), AND OTHER SOLID TUMORS (OST). Annals of Oncology. 255-255. 2008
- Recent advances in statistical methods for analyzing observational cohort studies: New opportunities for pharmaco-epidemiology. Pharmacoepidemiology and Drug Safety. S26-S27. 2008
- Meta-analysis of effects of zoledronic acid (ZOL) on survival in metastatic bone disease (MBD): Survival in patients with high bone turnover. Journal of Clinical Oncology. 20562-20562. 2008
- Survival benefits of zoledronic acid in patients with bone metastases from non-small cell lung cancer and high NTX levels: The role of BALP. Journal of Clinical Oncology. 19003-19003. 2008
- The prognostic value of pain scores for clinical outcomes in advanced breast cancer and prostate cancer. Journal of Clinical Oncology. 22120-22120. 2008
- Serum lactate dehydrogenase (LDH) is a significant prognostic variable for survival in patients with metastatic breast cancer – a multivariate analysis. European Journal of Cancer, Supplement. 189-189. 2008
- Skeletal-related event (SRE) history, bone metastasis location and number affect SRE risk and patient survival in metastatic breast cancer. European Journal of Cancer, Supplement. 174-174. 2008
- Disease and treatment parameters significantly affect skeletal complications and survival in metastatic breast cancer. Bone. S61-S61. 2008
- Group for research and assessment of psoriasis and psoriatic arthritis-international multi-center psoriasis and psoriatic arthritis reliability trial (GRAPPA-IMPART): Assessment of psoriasis, nail lesions, peripheral arthritis, and dactylitis. Journal of the American Academy of Dermatology. AB123-AB123. 2008
- OC4. Number and sites of bone lesions and history of skeletal-related events (SREs): Do these parameters correspond with skeletal morbidity and mortality in patients with bone metastases (mets) from hormone-refractory prostate cancer (HRPC)?. Cancer Treatment Reviews. 50-51. 2008
- P61. Identification of serum lactate dehydrogenase (LDH) as a significant prognostic variable for survival: Multivariate analysis in women with metastatic breast cancer (BC). Cancer Treatment Reviews. 28-29. 2008
- P62. Prognostic variables for occurrence of skeletal-related events (SREs) in patients with breast cancer metastatic to bone: A multivariate analysis. Cancer Treatment Reviews. 28-28. 2008
- P79. N-Telopeptide of type I collagen (NTX) levels and prognosis in patients with bone metastases from non-small cell lung cancer (NSCLC) receiving zoledronic acid (ZOL) or placebo. Cancer Treatment Reviews. 42-42. 2008
- P81. Meta-analysis of effects of zoledronic acid (ZOL) on survival in patients with metastatic bone disease (MBD) and high bone turnover. Cancer Treatment Reviews. 43-43. 2008
- Natural history of skeletal complications in patients receiving chemotherapy for breast cancer metastatic to bone. Breast Cancer Research and Treatment. S103-S103. 2007
- Patients' disease and treatment parameters significantly affect survival in metastatic breast cancer. Breast Cancer Research and Treatment. S102-S103. 2007
- Survival in breast cancer patients with bone metastases and reductions in markers of bone resorption during zoledronic acid treatment.. Breast Cancer Research and Treatment. S39-S39. 2007
- Gender differences in bleeding problems and implications for the assessment of a bleeding disorder. Blood. 639A-639A. 2007
- Increased levels of urinary N-telopeptide of type I collagen correlate with reduced survival in patients with advanced multiple myeloma. Blood. 449A-449A. 2007
- Predictors for skeletal-related events in patients with advanced multiple myeloma. Blood. 443A-444A. 2007
- 304 ORAL Early normalization of elevated baseline bone resorption marker levels by zoledronic acid and improved survival in patients with bone metastases from solid tumors. European Journal of Cancer, Supplement. 58-58. 2007
- 515 POSTER Zoledronic Acid (ZOL) treatment may improve survival in patients with lung cancer and high baseline N-telopeptide levels: a multivariate Cox regression analysis. European Journal of Cancer, Supplement. 94-94. 2007
- D5-07: Survival and zoledronic acid-induced normalization of bone marker levels in patients with non-small cell lung cancer. Journal of Thoracic Oncology. S406-S406. 2007
- PD6-3-7: Bone metastases from non-small cell lung cancer (NSCLC) result in meaningful skeletal morbidity within a patient’s lifetime. Journal of Thoracic Oncology. S434-S434. 2007
- PD6-3-8: Skeletal morbidity and zoledronic acid benefits in patients with bone metastases from non-small cell lung cancer. Journal of Thoracic Oncology. S435-S435. 2007
- Evaluating patient self-reported instruments in spondyloarthritis: Results from the international spondyloarthritis inter-observer reliability exercise the inspire study. Journal of Rheumatology. 1608-1609. 2007
- Multistate Analysis of Skeletal Events in Patients with Bone Metastases. Clinical Cancer Research. 6264s-6269s. 2006
- A Pre/Post observational study of the impact on transfusion reactions by the implementation of the 'Buffy Coat' method. Transfusion. 85A-86A. 2006
- Evaluating enthesitis in patients with spondyloarthritis (SpA).. Arthritis and Rheumatism. S724-S724. 2006
- INSPIRE hip mobility: A new method to measure hip mobility in patients with rheumatic diseases.. Arthritis and Rheumatism. S473-S474. 2006
- INSPIRE lateral flexion: A new method to measure lateral spinal mobility in patients with spondyloarthritis.. Arthritis and Rheumatism. S476-S476. 2006
- INternational SPondyloarthritis Inter-observer Reliability Exercise - The INSPIRE study.. Arthritis and Rheumatism. S724-S725. 2006
- Inspire hip mobility: A new method to measure hip mobility in patients with rheumatic diseases. Annals of the Rheumatic Diseases. 534-534. 2006
- Inspire lateral flexion: A new method to measure lateral spinal mobility in patients with spondyloarthritis (SpA). Annals of the Rheumatic Diseases. 208-208. 2006
- International spondyloarthritis inter-observer reliability exercise - The inspire study. Annals of the Rheumatic Diseases. 217-217. 2006
- Effect of zoledronic acid (Z) treatment based on serum parathyroid hormone (PTH) levels in patients (pts) with malignant bone disease.. Journal of Clinical Oncology. 495S-495S. 2006
- Effects of zoledronic acid on survival in patients with lung cancer and high baseline N-telopeptide (NTX) levels: Stratified by baseline bone alkaline phosphatase (BALP).. Journal of Clinical Oncology. 421S-421S. 2006
- Predictors of clinical outcome in patients with bone metastases from prostate cancer.. Journal of Clinical Oncology. 230S-230S. 2006
- Effect of zoledronic acid (Z) treatment based on serum parathyroid hormone (pTH) levels in patients (pts) with malignant bone disease. Annals of Oncology. XI73-XI74. 2006
- Prognostic significance of persistently elevated N-telopeptide levels in patients with bone metastases from solid tumors. Annals of Oncology. 254-255. 2006
- Zoledronic acid may improve survival in lung cancer patients with high baseline bone marker levels. Annals of Oncology. 221-221. 2006
- A multicenter, randomized, controlled clinical pilot trial of the feasibility of an intensive RBC transfusion policy for patients with acute leukemia treated with induction chemotherapy or stem cell transplant.. Blood. 126B-126B. 2005
- A revisit of the criteria to define remission in patients with idiopathic thrombocytopenia undergoing splenectomy.. Blood. 846A-846A. 2005
- Baseline N-telopeptide levels correlate with risk of skeletal morbidity in patients with multiple myeloma during zoledronic acid therapy.. Blood. 964A-965A. 2005
- Prognostic significance of biochemical markers of bone metabolism in patients with bone lesions from multiple myeloma (MM).. Blood. 335B-335B. 2005
- Breast cancer patients with persistently increased bone resorption. European Journal of Cancer, Supplement. 121-121. 2005
- Insights into the risk of bleeding in thrombocytopenic patients with acute leukemia. Transfusion. 12A-13A. 2005
- Patient self-assessment of bleeding symptoms. Transfusion. 145A-145A. 2005
- Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid. Journal of Clinical Oncology. 4925-4935. 2005
- Natural history of rising serum PSA in men with castrate nonmetastatic prostate cancer.. Journal of Clinical Oncology. 381S-381S. 2005
- Suppression of bone turnover markers by zoledronic acid and correlation with clinical outcome.. Journal of Clinical Oncology. 11S-11S. 2005
- Normalization of urinary N-telopeptide levels by zoledronic acid correlates with improved survival in patients with bone metastases from breast cancer.. Breast Cancer Research and Treatment. S129-S129. 2005
- The use of aprotinin to reduce transfusion requirements in children undergoing cardiac surgery: A meta-analysis.. Blood. 742A-742A. 2004
- Clinical Endpoints for Assessing Bisphosphonate Efficacy in the Prevention of Skeletal Complications of Bone Metastases. European Urology, Supplements. 34-39. 2004
- Impact of non-compliance and non-persistence with daily Bisphosphonates on longer-term effectiveness outcomes in patients with osteoporosis.. Journal of Bone and Mineral Research. S445-S445. 2004
- Survival-adjusted multiple event analysis of skeletal complications front bone metastases: A comprehensive analysis of treatment benefit. Journal of Bone and Mineral Research. 1595-1595. 2004
- The predictive value of bone resorption and formation markers in patients with prostate cancer metastatic to bone. Journal of Bone and Mineral Research. 1596-1596. 2004
- The prognostic significance of biochemical markers of bone metabolism in patients with bone metastases from solid tumors other than breast and prostate cancer. Journal of Bone and Mineral Research. 1596-1596. 2004
- Zoledronic acid reduces the need for radiation to bone in patients with breast or prostate cancer metastatic to bone: A survival-adjusted cumulative incidence analysis.. Journal of Clinical Oncology. 743S-743S. 2004
- Impact of non-compliance and non-persistence with daily bisphosphonates on longer-term effectiveness outcomes in patients with osteoporosis treated in tertiary specialist care. Annals of the Rheumatic Diseases. 96-97. 2004
- Longer term effectiveness outcomes of noncompliance and nonpersistence with daily regimen bisphosphonate therapy in patients with osteoporosis treated in tertiary specialist care. Osteoporosis International. S107-S107. 2004
- Survival-adjusted cumulative event analysis of skeletal-related events in patients with cancer metastatic to bone in trials of zoledronic acid. Bone. S88-S88. 2004
- Zoledronic acid reduces the survival-adjusted cumulative incidence of radiotherapy to bone in patients with bone metastases from breast or prostate cancer. Annals of Oncology. 124-124. 2004
- Comparison of heparin-induced thrombocytopenia antibody (HIT-Ab) generation and in vitro cross-reactivity after elective hip or knee replacement surgery in patients receiving Antithrombotic prophylaxis with fondaparinux or enoxaparin.. Blood. 164A-164A. 2003
- Predictors of infection and bleeding in patients with chemotherapy induced thrombocytopenia. Blood. 556A-557A. 2003
- Comparison of methods for the analysis of bleeding outcomes in platelet transfusion studies. Transfusion. 31A-31A. 2003
- Success in achieving a targeted platelet dose: What dose are we actually giving?. Transfusion. 30A-31A. 2003
- The clinical assessment of patients with psoriatic arthritis (PsA): Results of a validation study of the Spondyloarthritis Research Consortium of Canada.. Arthritis and Rheumatism. S168-S168. 2003
- A prospective study of clinical laboratory findings in patients referred by a hematologist for investigation of a suspected platelet disorder.. Blood. 690A-690A. 2002
- Using meta-analysis to explain heterogeneity among studies investigating the link between electromagnetic fields (EMF) and childhood leukemia.. American Journal of Epidemiology. S124-S124. 2001
- Development of a predictive model to identify multiplex families in psoriatic arthritis (PsA). Arthritis and Rheumatism. S334-S334. 1998
- The long-term use of azathioprine (AZA) in patients with psoriatic arthritis (PsA).. Arthritis and Rheumatism. S76-S76. 1998
- HLA markers and progression in psoriatic arthritis (PsA).. Arthritis and Rheumatism. 1090-1090. 1997
- Reliability and responsiveness of radiological scoring methods in psoriatic arthritis. Arthritis and Rheumatism. 1387-1387. 1997
- Responsiveness of three health status measures to changes in health in patients with psoriatic arthritis (PsA).. Arthritis and Rheumatism. 203-203. 1997
- Sulfasalzine in psoriatic arthritis: Clinical and radiological outcome.. Arthritis and Rheumatism. 191-191. 1997
- Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis (PsA).. Arthritis and Rheumatism. 1386-1386. 1996